Symbols / DFTX Stock $22.48 -3.35% Definium Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
DFTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Robert Barrow
Exch · Country NMS · United States
Market Cap 2.24B
Enterprise Value 1.87B
Income -183.79M
Sales —
FCF (ttm) -57.81M
Book/sh 3.36
Cash/sh 4.13
Employees 105
Insider 10d —
IPO Nov 15, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -13.03
PEG —
P/S —
P/B 6.68
P/C —
EV/EBITDA -11.25
EV/Sales —
Quick Ratio 6.17
Current Ratio 6.29
Debt/Eq 12.21
LT Debt/Eq —
EPS (ttm) -2.06
EPS next Y -1.73
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-26
ROA -28.01%
ROE -64.06%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 99.70M
Shs Float 93.69M
Insider Own 1.39%
Instit Own 71.86%
Short Float 9.91%
Short Ratio 5.69
Short Interest 9.82M
52W High 26.25
vs 52W High -14.36%
52W Low 6.03
vs 52W Low 272.80%
Beta 2.56
Impl. Vol. 80.08%
Rel Volume 1.46
Avg Volume 1.76M
Volume 2.57M
Target (mean) $38.53
Tgt Median $37.00
Tgt Low $25.00
Tgt High $70.00
# Analysts 15
Recom Strong_buy
Prev Close $23.26
Price $22.48
Change -3.35%
About

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$38.87
Mean price target
2. Current target
$22.48
Latest analyst target
3. DCF / Fair value
$-10.44
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$22.48
Low
$25.00
High
$70.00
Mean
$38.87

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-22 main Leerink Partners Outperform → Outperform $30
2026-04-17 init Stifel — → Buy $30
2026-04-16 main Canaccord Genuity Buy → Buy $38
2026-04-10 init Piper Sandler — → Overweight $49
2026-03-02 main HC Wainwright & Co. Buy → Buy $70
2026-02-24 init Wolfe Research — → Outperform $25
2026-01-30 init Jefferies — → Buy $30
2026-01-23 main RBC Capital Outperform → Outperform $36
News
RSS: Latest DFTX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-25 SULLIVAN MARK R Officer — 10,702 $18.47 $197,666
2026-03-25 BARROW ROBERT B Chief Executive Officer — 24,431 $18.47 $451,241
2026-03-25 KARLIN DANIEL ROLLINGS Officer — 8,018 $18.47 $148,092
2026-02-03 SULLIVAN MARK R Officer — 125,000 $0.00 $0
2026-02-03 ROBERTS BRANDI L Chief Financial Officer — 150,000 $0.00 $0
2026-02-03 WILEY MATTHEW T Officer — 115,000 $0.00 $0
2026-02-03 BARROW ROBERT B Chief Executive Officer — 320,000 $0.00 $0
2026-02-03 KARLIN DANIEL ROLLINGS Officer — 150,000 $0.00 $0
2025-12-26 SULLIVAN MARK R Officer — 11,276 $13.15 $148,244
2025-12-26 BARROW ROBERT B Chief Executive Officer — 25,791 $13.15 $339,072
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
166.31
+60.04%
103.92
+10.71%
93.87
+41.51%
66.33
Research And Development
117.67
+80.20%
65.30
+25.27%
52.12
+44.11%
36.17
Selling General And Administration
48.64
+25.96%
38.62
-7.48%
41.74
+38.39%
30.16
General And Administrative Expense
48.64
+25.96%
38.62
-7.48%
41.74
+38.39%
30.16
Other Gand A
48.64
+25.96%
38.62
-7.48%
41.74
+38.39%
30.16
Total Expenses
166.31
+60.04%
103.92
+10.71%
93.87
+41.51%
66.33
Operating Income
-166.31
-60.04%
-103.92
-10.71%
-93.87
-41.51%
-66.33
Total Operating Income As Reported
-166.31
-60.04%
-103.92
-10.71%
-93.87
-41.51%
-66.33
EBITDA
-178.31
-68.43%
-105.87
-15.51%
-91.65
-45.13%
-63.15
Normalized EBITDA
-155.35
-69.17%
-91.83
-7.82%
-85.17
-19.64%
-71.19
Reconciled Depreciation
0.00
-100.00%
0.53
-83.33%
3.16
-0.57%
3.18
EBIT
-178.31
-67.59%
-106.40
-12.22%
-94.81
-42.94%
-66.33
Total Unusual Items
-22.96
-63.57%
-14.04
-116.67%
-6.48
-180.60%
8.04
Total Unusual Items Excluding Goodwill
-22.96
-63.57%
-14.04
-116.67%
-6.48
-180.60%
8.04
Special Income Charges
0.00
-100.00%
2.54
0.00
—
Other Special Charges
—
-2.54
—
—
Net Income
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Pretax Income
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Net Non Operating Interest Income Expense
5.48
-40.94%
9.28
+98.86%
4.66
+211.97%
1.50
Interest Expense Non Operating
5.48
+140.12%
2.28
+148.15%
0.92
—
Net Interest Income
5.48
-40.94%
9.28
+98.86%
4.66
+211.97%
1.50
Interest Expense
5.48
+140.12%
2.28
+148.15%
0.92
—
Interest Income Non Operating
10.96
-5.17%
11.56
+106.98%
5.58
—
Interest Income
10.96
-5.17%
11.56
+106.98%
5.58
—
Other Income Expense
-22.96
-63.57%
-14.04
-114.98%
-6.53
-181.22%
8.04
Other Non Operating Income Expenses
—
—
-0.05
-2650.00%
0.00
Gain On Sale Of Security
-22.96
-38.50%
-16.58
-155.89%
-6.48
-180.60%
8.04
Tax Provision
—
—
—
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Net Income From Continuing Operation Net Minority Interest
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Net Income From Continuing And Discontinued Operation
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Net Income Continuous Operations
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Normalized Income
-160.83
-69.94%
-94.64
-6.04%
-89.25
-37.66%
-64.83
Net Income Common Stockholders
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Diluted EPS
—
-1.54
+36.89%
-2.44
-32.61%
-1.84
Basic EPS
—
-1.54
+36.89%
-2.44
-32.61%
-1.84
Basic Average Shares
—
70.46
+79.94%
39.16
+26.90%
30.86
Diluted Average Shares
—
70.46
+79.94%
39.16
+26.90%
30.86
Diluted NI Availto Com Stockholders
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Total Other Finance Cost
—
—
-4.66
-211.97%
-1.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
440.10
+45.66%
302.15
+142.61%
124.54
-26.74%
169.99
Current Assets
419.32
+48.90%
281.62
+171.12%
103.87
-28.88%
146.06
Cash Cash Equivalents And Short Term Investments
411.59
+50.36%
273.74
+174.55%
99.70
-29.86%
142.14
Cash And Cash Equivalents
257.84
-5.81%
273.74
+174.55%
99.70
-29.86%
142.14
Cash Financial
—
—
—
—
Other Short Term Investments
153.76
0.00
—
—
Prepaid Assets
—
—
—
3.91
Other Current Assets
7.73
-1.93%
7.88
+89.04%
4.17
+6.52%
3.91
Total Non Current Assets
20.78
+1.21%
20.53
-0.67%
20.67
-13.66%
23.94
Goodwill And Other Intangible Assets
19.92
+0.00%
19.92
-2.58%
20.45
-13.39%
23.61
Goodwill
19.92
+0.00%
19.92
+0.00%
19.92
+0.00%
19.92
Other Intangible Assets
—
—
0.53
-85.71%
3.69
Other Non Current Assets
0.86
+40.62%
0.61
+173.66%
0.22
-32.33%
0.33
Total Liabilities Net Minority Interest
107.77
+77.54%
60.70
+30.81%
46.41
+143.27%
19.08
Current Liabilities
66.70
+71.69%
38.85
+20.48%
32.25
+80.23%
17.89
Payables And Accrued Expenses
16.33
+93.57%
8.43
-24.99%
11.24
+134.74%
4.79
Payables
5.35
+166.02%
2.01
-71.19%
6.98
+89.75%
3.68
Accounts Payable
5.35
+166.02%
2.01
-51.40%
4.14
+95.93%
2.11
Other Payable
—
—
2.84
+81.42%
1.57
Current Accrued Expenses
10.98
+70.91%
6.42
+50.55%
4.27
+283.38%
1.11
Pensionand Other Post Retirement Benefit Plans Current
9.47
+47.81%
6.41
+41.52%
4.53
+41.53%
3.20
Current Debt And Capital Lease Obligation
—
—
—
0.07
Current Capital Lease Obligation
—
—
—
0.07
Other Current Liabilities
40.91
+70.37%
24.01
+45.73%
16.48
+66.36%
9.90
Total Non Current Liabilities Net Minority Interest
41.08
+87.95%
21.85
+54.33%
14.16
+1096.03%
1.18
Long Term Debt And Capital Lease Obligation
40.58
+85.68%
21.85
+54.67%
14.13
—
Long Term Debt
40.58
+85.68%
21.85
+54.67%
14.13
—
Tradeand Other Payables Non Current
—
—
—
—
Other Non Current Liabilities
0.50
—
0.03
-97.30%
1.18
Stockholders Equity
332.33
+37.64%
241.45
+209.02%
78.13
-48.23%
150.92
Common Stock Equity
332.33
+37.64%
241.45
+209.02%
78.13
-48.23%
150.92
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Share Issued
98.78
+31.52%
75.10
+82.72%
41.10
+8.22%
37.98
Ordinary Shares Number
98.78
+31.52%
75.10
+82.72%
41.10
+8.22%
37.98
Additional Paid In Capital
913.91
+42.91%
639.51
+73.78%
367.99
+6.74%
344.76
Retained Earnings
-582.67
-46.08%
-398.88
-37.45%
-290.20
-49.23%
-194.47
Gains Losses Not Affecting Retained Earnings
1.08
+32.48%
0.82
+138.78%
0.34
-45.30%
0.63
Other Equity Adjustments
1.08
+32.48%
0.82
+138.78%
0.34
-45.30%
0.63
Total Equity Gross Minority Interest
332.33
+37.64%
241.45
+209.02%
78.13
-48.23%
150.92
Total Capitalization
372.91
+41.63%
263.30
+185.38%
92.26
-38.87%
150.92
Working Capital
352.62
+45.25%
242.77
+238.94%
71.63
-44.11%
128.16
Invested Capital
372.91
+41.63%
263.30
+185.38%
92.26
-38.87%
150.92
Total Debt
40.58
+85.68%
21.85
+54.67%
14.13
+19523.61%
0.07
Capital Lease Obligations
—
—
—
0.07
Net Tangible Assets
312.41
+41.02%
221.53
+284.01%
57.69
-54.69%
127.31
Tangible Book Value
312.41
+41.02%
221.53
+284.01%
57.69
-54.69%
127.31
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-131.56
-66.26%
-79.13
-22.94%
-64.36
-28.37%
-50.14
Cash Flow From Continuing Operating Activities
-131.56
-66.26%
-79.13
-22.94%
-64.36
-28.37%
-50.14
Net Income From Continuing Operations
-183.79
-69.12%
-108.68
-13.52%
-95.73
-68.55%
-56.80
Depreciation Amortization Depletion
0.00
-100.00%
0.53
-83.33%
3.16
-0.57%
3.18
Amortization Cash Flow
0.00
-100.00%
0.53
-83.33%
3.16
-0.57%
3.18
Depreciation And Amortization
0.00
-100.00%
0.53
-83.33%
3.16
-0.57%
3.18
Amortization Of Intangibles
0.00
-100.00%
0.53
-83.33%
3.16
-0.57%
3.18
Other Non Cash Items
1.69
+270.19%
-0.99
-312.18%
0.47
+988.37%
0.04
Stock Based Compensation
20.10
+18.82%
16.91
+11.39%
15.18
+10.77%
13.71
Operating Gains Losses
22.83
+38.82%
16.45
+162.19%
6.27
+196.64%
-6.49
Gain Loss On Investment Securities
22.83
+43.22%
15.94
+140.22%
6.64
+204.62%
-6.34
Net Foreign Currency Exchange Gain Loss
0.00
-100.00%
0.51
+239.39%
-0.36
-145.27%
-0.15
Change In Working Capital
9.44
+382.21%
-3.34
-153.24%
6.28
+266.08%
-3.78
Change In Prepaid Assets
0.15
+103.50%
-4.34
-11220.51%
0.04
+115.00%
-0.26
Change In Payables And Accrued Expense
9.29
+851.38%
0.98
-86.69%
7.34
+397.05%
-2.47
Change In Accrued Expense
5.96
+92.01%
3.10
-41.65%
5.32
+1378.37%
-0.42
Change In Payable
3.34
+256.96%
-2.13
-204.99%
2.02
+198.49%
-2.06
Change In Account Payable
3.34
+256.96%
-2.13
-204.99%
2.02
+198.49%
-2.06
Change In Other Working Capital
—
—
—
-0.18
Change In Other Current Assets
0.03
-37.50%
0.05
-5.88%
0.05
+128.33%
-0.18
Change In Other Current Liabilities
-0.04
-25.00%
-0.03
+97.22%
-1.15
-32.41%
-0.87
Investing Cash Flow
-151.61
0.00
—
0.00
Cash Flow From Continuing Investing Activities
-151.61
0.00
—
0.00
Net Investment Purchase And Sale
-151.61
0.00
—
—
Purchase Of Investment
-268.36
0.00
—
—
Sale Of Investment
116.75
0.00
—
—
Net Business Purchase And Sale
—
—
—
0.00
Purchase Of Business
—
—
—
0.00
Financing Cash Flow
267.27
+5.56%
253.20
+1058.90%
21.85
-63.00%
59.05
Cash Flow From Continuing Financing Activities
267.27
+5.56%
253.20
+1058.90%
21.85
-63.00%
59.05
Net Issuance Payments Of Debt
20.00
+100.00%
10.00
-53.89%
21.68
0.00
Issuance Of Debt
42.00
+320.00%
10.00
-55.61%
22.53
0.00
Repayment Of Debt
-22.00
0.00
+100.00%
-0.84
0.00
Long Term Debt Issuance
42.00
+320.00%
10.00
-55.61%
22.53
0.00
Long Term Debt Payments
-22.00
0.00
+100.00%
-0.84
0.00
Net Long Term Debt Issuance
20.00
+100.00%
10.00
-53.89%
21.68
0.00
Net Common Stock Issuance
258.86
+3.14%
250.98
0.00
-100.00%
42.30
Proceeds From Stock Option Exercised
1.04
+44.83%
0.72
+1361.22%
0.05
-99.74%
18.66
Net Other Financing Charges
-12.63
-48.49%
-8.50
-7558.77%
0.11
+105.98%
-1.91
Changes In Cash
-15.90
-109.13%
174.07
+509.41%
-42.52
-577.08%
8.91
Effect Of Exchange Rate Changes
-0.01
+76.67%
-0.03
-137.97%
0.08
+125.57%
-0.31
Beginning Cash Position
273.74
+174.55%
99.70
-29.86%
142.14
+6.44%
133.54
End Cash Position
257.84
-5.81%
273.74
+174.55%
99.70
-29.86%
142.14
Free Cash Flow
-131.56
-66.26%
-79.13
-22.94%
-64.36
-28.37%
-50.14
Interest Paid Supplemental Data
5.34
+140.02%
2.22
+316.48%
0.53
0.00
Amortization Of Securities
-1.82
0.00
—
—
Common Stock Issuance
258.86
+3.14%
250.98
0.00
-100.00%
42.30
Issuance Of Capital Stock
258.86
+3.14%
250.98
0.00
-100.00%
42.30
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category